A shorter 17-amino acid Humanin analog, AGA-(C8R)HNG17, was found to have 100-fold higher activity than HNG.
In plain wordsIn lab tests, a shortened Humanin analog was 100 times more active than the analog HNG.
- Peptide
- Humanin
- Outcome
- IncreaseBiological activity of AGA-(C8R)HNG17 versus HNG
- Study
n: not reported in source
- Comparator
- HNG
- Outcome group
- Neuroprotection · Nervous system and cognition
Source sentences
During additional mutational analysis, a shorter 17-amino acid form, AGA-(C8R)HNG17, was accidentally discovered to have a 100-fold higher activity than HNG.
In this study, Humanin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Humanin.